Advanced Endocrinology Fellow
UNIVERSITY OF CHICAGO
Chicago, IL, United States
Kerim B. Kaylan, MD, PhD, is an advanced endocrinology fellow and physician-scientist at the University of Chicago. His research is focused on the role of the β cell in the pathogenesis of type 1 diabetes.
He received his undergraduate degree in biomedical engineering from the University of Michigan, where his work in Dr. Shuichi Takayama's lab exposed him to the use of bioengineering for both biological inquiry and the improvement of human health. He subsequently entered the MD/PhD program at the University of Illinois at Urbana-Champaign, where he completed his doctoral research on liver tissue engineering with Dr. Gregory Underhill in the Department of Bioengineering. He continued his training through the Physician-Scientist Development Program at the University of Chicago. There, he completed his internal medicine residency and adult endocrinology fellowship.
While transitioning back to the bench from clinic in fellowship, he developed an interest in diabetes research and joined the laboratory of Dr. Raghavendra Mirmira to further pursue this interest. His initial efforts in Dr. Mirmira’s laboratory focused on the role of 12-lipoxygenase signaling in promoting β cell stress and immune cell crosstalk in the setting of both type 1 and type 2 diabetes. His current research focuses on β-cell inflammatory responses to viral stimuli in type 1 diabetes. His research has been supported by the NIDDK K12 Diabetes Doctors program, Breakthrough T1D, the Endocrine Fellows Foundation, and the Kovler Diabetes Center at the University of Chicago.
Dr. Kaylan finds it tremendously rewarding to take care of individuals living with diabetes. His long-term goal is to become a diabetologist focused on using his insights as a researcher and bioengineer to advance our understanding of disease and the clinical care patients receive.
Disclosure information not submitted.
SUN-224 - A Golgi-ER Ubiquitin Network Governing PD-L1 Stability in Islet Beta Cells
Sunday, June 14, 2026
9:00 AM - 4:00 PM CT
ORF21-01 - A Golgi-ER Ubiquitin Network Governing PD-L1 Stability in Islet Beta Cells
Sunday, June 14, 2026
9:30 AM - 9:35 AM CT
Monday, June 15, 2026
9:00 AM - 2:00 PM CT